These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 33683187)

  • 21. Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer.
    Li T; Han L; Ma S; Lin W; Ba X; Yan J; Huang Y; Tu S; Qin K
    Front Mol Biosci; 2023; 10():1140325. PubMed ID: 36950522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
    Yue SJ; Wang WX; Yu JG; Chen YY; Shi XQ; Yan D; Zhou GS; Zhang L; Wang CY; Duan JA; Tang YP
    Pharmacol Res; 2019 Oct; 148():104453. PubMed ID: 31541688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
    Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
    World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer and the gut microbiota: an unexpected link.
    Zitvogel L; Galluzzi L; Viaud S; Vétizou M; Daillère R; Merad M; Kroemer G
    Sci Transl Med; 2015 Jan; 7(271):271ps1. PubMed ID: 25609166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases.
    Richard ML; Sokol H
    Nat Rev Gastroenterol Hepatol; 2019 Jun; 16(6):331-345. PubMed ID: 30824884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota.
    Xue P; Sang R; Li N; Du S; Kong X; Tai M; Jiang Z; Chen Y
    Front Cell Infect Microbiol; 2023; 13():1119037. PubMed ID: 37091671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review.
    Zhao H; He M; Zhang M; Sun Q; Zeng S; Chen L; Yang H; Liu M; Ren S; Meng X; Xu H
    Am J Chin Med; 2021; 49(4):805-828. PubMed ID: 33827382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition.
    Zhang X; Zhao S; Song X; Jia J; Zhang Z; Zhou H; Fu H; Cui H; Hu S; Fang M; Liu X; Bian Y
    J Pharmacol Sci; 2018 Aug; 137(4):324-332. PubMed ID: 30150145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Gut Microbiota and Gastrointestinal Cancer.
    Meng C; Bai C; Brown TD; Hood LE; Tian Q
    Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):33-49. PubMed ID: 29474889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
    Malla RR
    Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected guests in the tumor microenvironment: microbiome in cancer.
    Wong-Rolle A; Wei HK; Zhao C; Jin C
    Protein Cell; 2021 May; 12(5):426-435. PubMed ID: 33296049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the gut microbiota on immune cell interactions and cancer treatment.
    Liu C; Fu L; Wang Y; Yang W
    J Transl Med; 2024 Oct; 22(1):939. PubMed ID: 39407240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbes and inflammation in colorectal cancer.
    Kostic AD; Chun E; Meyerson M; Garrett WS
    Cancer Immunol Res; 2013 Sep; 1(3):150-7. PubMed ID: 24777677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota and the development of pediatric diseases.
    Lu CY; Ni YH
    J Gastroenterol; 2015 Jul; 50(7):720-6. PubMed ID: 25917564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.